- Current and Emerging BTKi-Based Regimens in Treatment Naïve CLL
- BTK Inhibition in R/R CLL/SLL: 2L and Beyond
- Clinical Scenarios: CLL/SLL
- ASCO & EHA 2025 Insights: Leukemias
- Emerging Induction & Maintenance Regimens in Newly Diagnosed MM
- R/R Multiple Myeloma: Practice Changing Data in CAR T and Bispecifics
- Live Q&A
OncLive® State of the Science Summit™ Hematologic Malignancies
Kimpton Hotel Monaco
620 William Penn Place
Pittsburgh, PA 15219
United States
Tuesday, June 24, 2025
6:00 PM-9:00 PM ET
Complimentary Parking
In-Person Only
Event Chair
Kathleen A Dorritie, MD
UPMC Hillman Cancer Center
IN PARTNERSHIP WITH
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512